Fir Tree Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

Fir Tree Capital Management’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-549,428	Closed	-$5.68M	–	237
2023 Q2	$5.68M	Buy	549,428 +251,653	+85%	+$2.58M	0.53%	42
2023 Q1	$3.02M	Buy	297,775 +6,506	+2%	+$65.6K	0.24%	150
2022 Q4	$2.9M	Sell	291,269 -208,731	-42%	-$2.06M	0.15%	203
2022 Q3	$4.88M	Hold	500,000	–	–	0.16%	203
2022 Q2	$4.86M	Hold	500,000	–	–	0.15%	218
2022 Q1	$4.85M	Hold	500,000	–	–	0.13%	233
2021 Q4	$4.84M	Hold	500,000	–	–	0.13%	229
2021 Q3	$4.84M	Buy	+500,000	New	+$4.88M	0.16%	193

Other funds holding NKGN

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Fir Tree Capital Management's NKGN Position: Q3 2023 in Review

Fir Tree Capital Management sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q3 2023, closing a stake of 549,428 shares — an estimated $5.68M sold.

Fir Tree Capital Management first reported a position in NKGN in Q3 2021 and held it in 8 quarters. The position peaked at $5.68M in Q2 2023. 13 funds tracked by Wall St. Rank hold NKGN as of Q3 2023.

Fir Tree Capital Management reported no remaining NKGen Biotech, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Fir Tree Capital Management sold 549,428 NKGen Biotech, Inc. Common Stock shares in Q3 2023, an estimated $5.68M.
Fir Tree Capital Management first reported a position in NKGen Biotech, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Fir Tree Capital Management's NKGen Biotech, Inc. Common Stock position peaked at $5.68M in Q2 2023.
13 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q3 2023.

Based on Fir Tree Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.